Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow.

Already subscribed? Sign in now

Learn more about CME

Statins for Primary and Secondary Prevention of Cardiovascular Disease

MoreVert
AddCircleOutlineFollow
ShareShare
AddCircleOutlineFollow
Follow
ShareShare
Share

You must be a subscriber to see the full topic content.

  • KeyboardArrowRight

    Overview and Recommendations

    • Background

    • Evaluation

    • KeyboardArrowRight

      Management

      • Primary prevention

      • Secondary prevention

      • Blood test monitoring for statin users

  • Related Summaries

  • Overview

  • KeyboardArrowRight

    Recommendations

    • KeyboardArrowRight

      United States recommendations

      • American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Clinical Practice Guidelines - 2018 cholesterol clinical practice guidelines

      • United States Preventive Services Task Force (USPSTF) recommendations

      • Comparison of USPSTF and ACC/AHA recommendations

    • United Kingdom recommendations

    • European Society of Cardiology/European Atherosclerosis Society recommendations

    • Canadian Cardiovascular Society guidelines

  • Efficacy Across Populations

  • KeyboardArrowRight

    Patients with Cardiovascular Disease (Secondary Prevention)

    • Systematic reviews

    • KeyboardArrowRight

      Comparisons of dose intensity

      • High-dose vs. low-dose statins

      • Atorvastatin 80 mg vs. atorvastatin 10 mg

      • Atorvastatin 80 mg vs. pravastatin 40 mg

      • Atorvastatin 80 mg vs. simvastatin 20 mg

      • Rosuvastatin 40 mg vs. atorvastatin 80 mg

      • Simvastatin 80 mg vs. simvastatin 20 mg

    • KeyboardArrowRight

      Selected randomized placebo-controlled trials

      • Pravastatin trials

      • Simvastatin trials

      • Other statin trials

  • KeyboardArrowRight

    Primary Prevention of Heart Disease

    • Efficacy for primary prevention

    • Efficacy in patients with low or normal cholesterol levels

  • Women

  • KeyboardArrowRight

    Elderly

    • Statin Recommendations for Elderly Patients from Professional organizations

    • Evidence for Statins in Elderly Patients

  • KeyboardArrowRight

    Other Specific Populations

    • Children and adolescents

    • Asian patients

    • Patients with diabetes

    • Patients with familial hypercholesterolemia (FH)

    • Patients with heart failure

    • Heart transplant recipients

    • KeyboardArrowRight

      Patients with chronic kidney disease

      • Statins in chronic kidney disease (CKD) patients not on dialysis

      • Statins in dialysis patients

      • Statins in renal transplant recipients

      • Reviews of statins in renal disease

    • High cholesterol absorbers

    • Patients with abnormal liver function test

    • Patients with life-limiting illness

  • KeyboardArrowRight

    Prevention of Stroke

    • Statins for primary prevention of stroke

    • Statins for secondary prevention of stroke

  • KeyboardArrowRight

    Comparative Efficacy

    • Comparative efficacy for clinical outcomes

    • Comparative efficacy for lipid levels

  • Adverse effects of statins

  • KeyboardArrowRight

    Guidelines and Resources

    • KeyboardArrowRight

      Guidelines

      • United States guidelines

      • United Kingdom guidelines

      • Canadian guidelines

      • European guidelines

    • Review articles

  • Patient Decision Aids

  • Patient Information

  • KeyboardArrowRight

    Quality Improvement

    • Physician Quality Reporting System Quality Measures

  • KeyboardArrowRight

    References

    • General references used

    • Recommendation grading systems used

    • Synthesized Recommendation Grading System for DynaMed

    • DynaMed Editorial Process

    • Special acknowledgements

    • How to cite

Topic Editor
Lavanya Bellumkonda MD
KeyboardArrowDown
Affiliations

Assistant Professor in Medicine and Associate Medical Director, Center for Advanced Heart Failure, Yale University School of Medicine; Connecticut, United States; Medical Director, Verdi 5 East, Yale New Haven Hospital; Connecticut, United States

Recommendations Editor
Zbys Fedorowicz MSc, DPH, BDS, LDSRCS
KeyboardArrowDown
Affiliations

Director of Bahrain Branch of the United Kingdom Cochrane Center, The Cochrane Collaboration; Awali, Bahrain

Conflicts of Interest

Dr. Fedorowicz declares no relevant financial conflicts of interest.

Deputy Editor
Peter Oettgen MD
KeyboardArrowDown
Affiliations

Editor in Chief, DynaMed; Cardiologist, Beth Israel Deaconess Medical Center; Massachusetts, United States; Associate Professor of Medicine, Harvard Medical School; Massachusetts, United States

Conflicts of Interest

Dr. Oettgen declares no relevant financial conflicts of interest.

CheckCircle

top